Trials / Completed
CompletedNCT03224520
Smoker-to-Smoker (S2S) Peer Marketing and Messaging to Disseminate Tobacco Interventions
Smoker-to-Smoker (S2S) Peer Marketing and Messaging to Disseminate Tobacco
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 1,487 (actual)
- Sponsor
- University of Massachusetts, Worcester · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The research study, "Smoker-to-Smoker (S2S) Peer Marketing and Messaging to Disseminate Tobacco Interventions" will test two smoker-driven, social marketing innovations to recruit and engage smokers in Decide2Quit.org (Decide2Quit), which is an evidence-based, effective "Digital Intervention for Smoking Cessation".
Detailed description
S2S has many innovations that are designed to utilize the power of peers and social networks for dissemination. These include: Peer recruitment: Tools to facilitate smokers' recruiting their peers to increase Decide2Quit access; and a recommender computer tailored health communication (recommender CTHC): a Complex machine learning algorithm (recommender systems) that uses smokers' feedback (explicit and implicit) in the current and prior studies to adapt its selection of messages to smokers. Using a 2×2 factorial design, the study will compare individually and collectively the enhancements (recruitment, use, and effectiveness) offered by the S2S functions over the standard version of Decide2Quit (online recruitment and standard CTHC), an active comparison group.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Recommender CTHC | Enhanced Messaging |
| BEHAVIORAL | Standard CTHC | Standard Messaging |
| OTHER | Peer Recruitment | Tools to facilitate smokers' recruiting their peers |
| OTHER | Standard Online Recruitment | Search Engine and Social Media Advertisements |
Timeline
- Start date
- 2017-12-20
- Primary completion
- 2019-11-01
- Completion
- 2020-03-13
- First posted
- 2017-07-21
- Last updated
- 2021-03-26
- Results posted
- 2021-02-10
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03224520. Inclusion in this directory is not an endorsement.